Tirzepatide and Birth Control Pills: What the Zepbound Label Says

Yes, tirzepatide can make birth control pills less reliable for a while. The current US labels for both Zepbound and Mounjaro tell people who use oral hormonal contraceptives to switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase.

That's the short answer. The longer one explains why the window exists, why it keeps coming back, and why you shouldn't copy-paste this rule onto every GLP-1 medicine. (This is label information, not personal advice. Your prescriber or pharmacist can help you build a plan that fits you.)

What do the Zepbound and Mounjaro labels actually say?

Both tirzepatide labels on DailyMed (revised August 2026) give the same instruction in section 7.2 on oral medications. Advise people using oral hormonal contraceptives to:

• switch to a non-oral contraceptive method, or
• add a barrier method for 4 weeks after starting the medicine and for 4 weeks after each dose escalation.

Section 8.3 adds the reason: tirzepatide "may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying." The Mounjaro label adds two helpful details. The delay "is largest after the first dose and diminishes over time." And hormonal contraceptives that aren't taken by mouth "should not be affected."

Why would a weekly shot affect a daily pill?

It's not a hormone interaction in the usual sense. It's about traffic. Tirzepatide slows the rate at which your stomach empties, especially early on. A pill that normally moves into your small intestine and gets absorbed on schedule ends up waiting in line.

The labels include a small pharmacology study that shows the effect. People took a combined pill (0.035 mg ethinyl estradiol plus 0.25 mg norgestimate) alongside a single 5 mg dose of tirzepatide:

What was measured	Ethinyl estradiol	Norgestimate	Norelgestromin
Peak level (Cmax)	down 59%	down 66%	down 55%
Total exposure (AUC)	down 20%	down 21%	down 23%
Time to peak	delayed 2.5–4.5 hours

So the peak levels dropped a lot, the total amount absorbed dropped by about a fifth, and everything arrived hours late. The labels don't say exactly how much protection is lost. They take the cautious route and recommend backup during the windows when gastric emptying is slowed the most.

If you want the bigger picture of how slowed digestion can affect any medicine you swallow, we cover it in GLP-1 delayed gastric emptying and oral medications.

When does the 4-week window apply?

This is where people get caught out. The window isn't a one-time thing at the start. It restarts with every dose escalation. On a typical tirzepatide schedule with several step-ups, you could have several of these windows across the first months.

A simple way to picture it:

Event	Backup window per the label
First dose	4 weeks after starting
Each step up to a higher dose	4 weeks after that increase
Staying on the same dose	No window listed in the label

Restarting after a long break isn't spelled out in this section of the label. That's a good question for your prescriber, since restarts often begin at a lower dose again (see restarting a GLP-1 after a break).

Tracking tip: Dose-change dates are easy to forget. If you log your shots in GLPily, each dose change shows up in your shot history, so you can count four weeks from the actual date instead of guessing.

Does this apply to Ozempic, Wegovy and other GLP-1s?

Not in the same way, and this is why "GLP-1s affect the pill" is too broad. Here's what current US labels say:

Medicine	What the label says about oral contraceptives
Zepbound / Mounjaro (tirzepatide)	Switch to non-oral or add a barrier method for 4 weeks after starting and after each dose increase
Foundayo (orforglipron tablets)	Switch to non-oral or add a barrier method for 30 days after starting and after each dose increase. The label notes the effect on pill absorption "has not been evaluated in a clinical trial."
Wegovy (semaglutide injection and tablets)	In its pharmacology section, it lists ethinyl estradiol and levonorgestrel among drugs with "no clinically significant differences" in levels when used with semaglutide. There's a general advice to monitor oral medicines, but no 4-week backup instruction.

Foundayo is the newer daily pill. Our Foundayo guide has the background. Oral Wegovy and other semaglutide products have their own labels, and "no instruction" isn't the same as "no question worth asking." If you take any GLP-1 and the pill, ask your pharmacist to check your exact product, because labels get updated. Here's how to find the current prescribing information yourself.

What about vomiting or diarrhea?

Separate from the gastric-emptying effect, the usual birth-control rule applies. Stomach upset can keep a pill from being absorbed. Nausea and vomiting are among the most common tirzepatide side effects, especially after dose increases, which is the same window when the label already advises backup. If you vomit soon after taking a pill or have severe diarrhea, check your pill's own leaflet for its missed-pill or vomiting instructions, or ask a pharmacist.

Questions to bring to your prescriber or pharmacist

• "I take [pill name]. Should I switch methods, or use condoms during the label's 4-week windows?"
• "When are my planned dose increases, so I know when each window starts?"
• "Would a patch, ring, IUD, implant or injection make more sense for me while I'm on tirzepatide?"
• "If my dose is paused or restarted, does that change anything?"
• "If I'm planning a pregnancy, what's the timing for stopping this medicine?"

On that last point, pregnancy planning and fertility deserve their own conversation. Some people find cycles change as weight changes. We gather what's known in GLP-1 medication and fertility.

If you think you may already be at risk of pregnancy, say so right away. A pharmacist can talk you through time-sensitive options like emergency contraception.

Common questions

How long should I use backup birth control on Zepbound or Mounjaro?

The labels say 4 weeks after starting and 4 weeks after each dose escalation, or switch to a non-oral method altogether. Your prescriber or pharmacist can confirm how this fits your schedule.

Does tirzepatide affect the patch, ring, IUD, implant or shot?

The Mounjaro label states that hormonal contraceptives not taken by mouth "should not be affected," because the issue is slowed absorption from the stomach.

Does Ozempic or Wegovy make the pill less effective?

The current Wegovy label reports no clinically significant change in ethinyl estradiol or levonorgestrel levels with semaglutide and doesn't include tirzepatide's 4-week instruction. Check your exact product's label with a pharmacist, because each medicine has its own.

Does the warning apply to progestin-only pills too?

The label wording covers "oral hormonal contraceptives," not one specific type. The study used a combined pill. Ask your pharmacist how it applies to your exact pill.